Hillner BE - Search Results

1

Intended versus inferred management after PET for cancer restaging: analysis of Medicare claims linked to a coverage with evidence development registry.

Hillner BE, Tosteson TD, Tosteson AN, Wang Q, Song Y, Onega T, Hanna LG, Siegel BA. Hillner BE, et al. Med Care. 2013 Apr;51(4):361-7. doi: 10.1097/MLR.0b013e318287d860. Med Care. 2013. PMID: 23481033 Free PMC article.

2

The National Oncologic PET Registry (NOPR): design and analysis plan.

Hillner BE, Liu D, Coleman RE, Shields AF, Gareen IF, Hanna L, Stine SH, Siegel BA. Hillner BE, et al. J Nucl Med. 2007 Nov;48(11):1901-8. doi: 10.2967/jnumed.107.043687. Epub 2007 Oct 17. J Nucl Med. 2007. PMID: 17942807 Free article.

3

Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry.

Hillner BE, Siegel BA, Liu D, Shields AF, Gareen IF, Hanna L, Stine SH, Coleman RE. Hillner BE, et al. J Clin Oncol. 2008 May 1;26(13):2155-61. doi: 10.1200/JCO.2007.14.5631. Epub 2008 Mar 24. J Clin Oncol. 2008. PMID: 18362365

4

Relationship between cancer type and impact of PET and PET/CT on intended management: findings of the national oncologic PET registry.

Hillner BE, Siegel BA, Shields AF, Liu D, Gareen IF, Hunt E, Coleman RE. Hillner BE, et al. J Nucl Med. 2008 Dec;49(12):1928-35. doi: 10.2967/jnumed.108.056713. Epub 2008 Nov 7. J Nucl Med. 2008. PMID: 18997054 Free article.

5

The impact of positron emission tomography (PET) on expected management during cancer treatment: findings of the National Oncologic PET Registry.

Hillner BE, Siegel BA, Shields AF, Liu D, Gareen IF, Hanna L, Stine SH, Coleman RE. Hillner BE, et al. Cancer. 2009 Jan 15;115(2):410-8. doi: 10.1002/cncr.24000. Cancer. 2009. PMID: 19016303 Free article.

6

Impact of dedicated brain PET on intended patient management in participants of the national oncologic PET Registry.

Hillner BE, Siegel BA, Shields AF, Duan F, Gareen IF, Hanna L, Coleman RE. Hillner BE, et al. Mol Imaging Biol. 2011 Feb;13(1):161-5. doi: 10.1007/s11307-010-0427-5. Mol Imaging Biol. 2011. PMID: 21080232 Free PMC article.

7

Growth in the use of PET for six cancer types after coverage by medicare: additive or replacement?

Hillner BE, Tosteson AN, Song Y, Tosteson TD, Onega T, Goodman DC, Siegel BA. Hillner BE, et al. J Am Coll Radiol. 2012 Jan;9(1):33-41. doi: 10.1016/j.jacr.2011.06.019. J Am Coll Radiol. 2012. PMID: 22221634 Free PMC article.

8

Impact of 18F-FDG PET used after initial treatment of cancer: comparison of the National Oncologic PET Registry 2006 and 2009 cohorts.

Hillner BE, Siegel BA, Hanna L, Shields AF, Duan F, Gareen IF, Quinn B, Coleman RE. Hillner BE, et al. J Nucl Med. 2012 May;53(5):831-7. doi: 10.2967/jnumed.112.103911. Epub 2012 Mar 23. J Nucl Med. 2012. PMID: 22448033 Free article.

9

Intended versus inferred care after PET performed for initial staging in the National Oncologic PET Registry.

Hillner BE, Tosteson AN, Tosteson TD, Wang Q, Song Y, Hanna LG, Siegel BA. Hillner BE, et al. J Nucl Med. 2013 Dec;54(12):2024-31. doi: 10.2967/jnumed.113.123430. Epub 2013 Nov 12. J Nucl Med. 2013. PMID: 24221994 Free PMC article.

10

Impact of 18F-fluoride PET in patients with known prostate cancer: initial results from the National Oncologic PET Registry.

Hillner BE, Siegel BA, Hanna L, Duan F, Shields AF, Coleman RE. Hillner BE, et al. J Nucl Med. 2014 Apr;55(4):574-81. doi: 10.2967/jnumed.113.130005. Epub 2014 Feb 27. J Nucl Med. 2014. PMID: 24578240 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

139 results

Search Page

Filters